Literature DB >> 34763086

WITHDRAWN: lncRNA Linc00173 modulates glucose metabolism and multidrug chemoresistance in SCLC: Potential molecular panel for targeted therapy.

Shuyu Wang1, Fanrui Zeng2, Shumei Liang3, Qiuping Wang3, Yang Wen3, Qiongyao Wang4, Jiexia Zhang5, Man Li3, Shun Fang3, Ting Wei4, Minglun Li6, Farkhad Manapov6, Jian Zhang7, Linlang Guo8.   

Abstract

This article has been withdrawn at the request of the editor-in-chief. Following publication of this article, the editor-in-chief discovered evidence of image duplication in Figures 1I, 1J, 3F, S5B, and S6B. Given the duplication of several western blots representing several gene products, the editor-in-chief has lost faith in the findings presented in this article. The authors maintain that these image duplications were the result of errors in file management and do not affect the conclusions of the study. The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/our-business/policies/article-withdrawal.
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Linc00173; YB1; glucose metabolism; in vitro; in vivo; long noncoding RNA; molecular mechanisms; multidrug resistance; small cell lung cancer; therapeutic targets; tissue samples

Year:  2021        PMID: 34763086     DOI: 10.1016/j.ymthe.2021.11.003

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   12.910


  3 in total

Review 1.  Targeted treatments of AL and ATTR amyloidosis.

Authors:  Pranav Chandrashekar; Anish K Desai; Barry H Trachtenberg
Journal:  Heart Fail Rev       Date:  2021-11-16       Impact factor: 4.654

2.  LncRNA SNHG1 promotes renal cell carcinoma progression through regulation of HMGA2 via sponging miR-103a.

Authors:  Zhi-Hua Ye; Ding-Wen Gui; Xiao-Ying Wang; Jing Wang; Jin-Lun Fu
Journal:  J Clin Lab Anal       Date:  2022-04-25       Impact factor: 3.124

3.  NXPH4 Promotes Gemcitabine Resistance in Bladder Cancer by Enhancing Reactive Oxygen Species and Glycolysis Activation through Modulating NDUFA4L2.

Authors:  Decai Wang; Pu Zhang; Zijian Liu; Yifei Xing'; Yajun Xiao
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.